News Novonesis A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:42 2024-05-14 am EDT			5-day change	1st Jan Change
420.5 ^DKK	+0.24%		+1.52%	+13.31%

May. 10	NOVONESIS : Key segments outperform in average Q1 24 showing
May. 03	Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024

NOVONESIS : Key segments outperform in average Q1 24 showing	May. 10
Trading by management and close relations of management	May. 08	GL
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	May. 03
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration	May. 03	GL
Trading statement Q1 2024	May. 03	GL
Novonesis Provides Sales Guidance for the Year 2024	May. 03	CI
Final dividend	Apr. 30	FA
Novonesis A/S : Resolutions from the annual shareholders' meeting 2024	Apr. 30	PU
Resolutions from the annual shareholders’ meeting 2024	Apr. 30	GL
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	Apr. 30	CI
Novonesis A/S : Invitation to the annual shareholders' meeting	Apr. 08	PU
Invitation to the annual shareholders’ meeting	Apr. 08	GL
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08	CI
Share-based legacy RSU program granted	Apr. 08	GL
China to speed up 'new productive forces', vice president says	Mar. 26	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	Mar. 21	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	Mar. 21
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21	RE
2024 outlook and pro forma financials	Mar. 21	GL
2024 outlook and pro forma financials	Mar. 21	AQ

No results for this search

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 12:32 pm EDT